GENE ONLINE|News &
Opinion
Blog

Biosimilar
Bora Pharmaceuticals Acquires 30.5% Stake in Tanvex Biopharma, Becomes Largest Corporate Shareholder
2024-08-28
Kyowa Kirin’s Strategic Partner Sandoz KK Receives Nod for Rituximab Biosimilar
2023-10-03
Novartis’ Generic-drugs Unit Partners with Samsung Bioepis for Biosimilar Drug Launch
2023-09-12
GeneOnline’s Weekly News Highlights: July 3-7
2023-07-10
Biocon and Viatris Hit Another FDA Wall with Avastin Biosimilar
2023-02-13
Celltrion’s Avastin Biosimilar Gets FDA Greenlight
2022-09-29
Organon Licenses Biosimilars From Shanghai’s Henlius For $103 Million
2022-06-14
Alymsys Becomes the Third Biosimilar for Bevacizumab Approved by FDA
2022-04-20
BBL to Take Over Biosimilars Business from Viatris 
2022-03-02
The Next SuperStar Drug? AbbVie Places its Hope on Skyrizi and Rinvoq
2022-02-16
Samsung Biologics Snaps Up Biogen’s Stake in Samsung Bioepis for $2.3 Billion, Assuming Full Control of Biosimilar Venture
2022-01-28
FDA Approves Samsung Bioepis and Biogen’s Lucentis Biosimilar
2021-09-22
South Korea’s Boryung Launches Avastin Biosimilar Developed by Samsung Bioepis
2021-09-02
Addressing The Global Need for Biosimilars: Current Trends, Expectations and Real World Experiences
2021-08-26
Novartis, Genentech Bag Key FDA Okay for Blockbuster Drug
2021-04-14
1 2
LATEST
Lupin Secures US FDA Tentative Approval for Oxcarbazepine ER Tablets Manufactured in Nagpur
2025-06-18
Investor Trust and Market Timing Shape the New IPO Playbook
2025-06-18
Global Pharmaceutical Sector Records $6.96 Billion in May 2025 Deal Activity with Three Major Agreements Driving 59 Percent of M&A Value
2025-06-18
Eli Lilly Acquires SiteOne Therapeutics to Develop Non-Opioid Pain Treatment STC-004
2025-06-18
New Device Promises to Streamline CAR T-Cell Therapy Production for Earlier Cancer Treatment
2025-06-18
Roche Reports Near-Complete Suppression of Disability Progression in RMS Patients Over Two Years with BTK Inhibitor
2025-06-18
Technological Advancements Reduce R&D Costs and Propel Growth of Cell and Gene Therapies in Biopharmaceutical Sector
2025-06-18
EVENT
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top